Deltex Medical Group Plc (DEMG):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Deltex Medical Group Plc (DEMG) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11422
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Deltex Medical Group Plc (Deltex Medical), formerly Chalkgrove Plc, is a medical device company that develops fluid management equipment and oesophageal doppler monitoring systems. The company offers products such as cardioQ-ODM+, probes, simulator, bougies, cerebral oximetry, video laryngoscopes and laryngoscopes. Its cardioQ-ODM+ is fluid management and cardiac output monitoring system to measure both flow and pressure directly. Deltex Medical’s products are used in critical care, enhanced recovery, pediatrics, and surgical use, among others. The company offers repair, support and training services. It has operations in Canada, Spain, the UK and the US. Deltex Medical is headquartered in Chichester, the UK.

Deltex Medical Group Plc (DEMG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Deltex Medical Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Deltex Medical Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Deltex Medical Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Deltex Medical Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Deltex Medical Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Deltex Medical Group Plc, Medical Equipment, Deal Details 10
Partnerships 10
CAS Medical Systems Enters into Distribution Agreement With Deltex Medical 10
Deltex Medical And Uscom Enter Distribution Agreement 11
Equity Offering 12
Deltex Medical Raises USD2.4 Million in Private Placement of Shares 12
Deltex Medical Plans to Raise USD0.5 Million in Rights Offering of Shares 13
Deltex Medical Raises USD0.7 Million in Private Placement of Shares 14
Deltex Medical Raises USD1.8 Million in Rights Offering of Shares 15
Deltex Medical to Raise USD6.7 Million in Private Placement of Shares 16
Deltex Medical Completes Private Placement Of Shares For US$4 Million 17
Deltex Medical Completes Private Placement Of Shares For US$0.2 Million 18
Deltex Medical Group Plc – Key Competitors 19
Deltex Medical Group Plc – Key Employees 20
Deltex Medical Group Plc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Strategy And Business Planning 22
Jan 18, 2017: Deltex Medical Group Announces Two additional US platform programme accounts: 30 platform accounts milestone passed 22
Financial Announcements 23
Sep 24, 2018: Deltex Medical Group: Interim results for the six-month period ended 30 June 2018 23
Sep 11, 2017: Deltex Medical Group: Interim results for the six months ended 30 June 2017 28
Apr 27, 2017: Deltex Medical: Results Summary for the year ended 31 December 2016 29
Jan 18, 2017: Deltex Medical Group Provides Trading update in respect of year ended 31 December 2016 35
Corporate Communications 37
Jun 13, 2018: Deltex Medical Announces Senior Management Change 37
Product News 38
Feb 08, 2018: Suite of solutions delivers monitoring for all, says Deltex at EBPOM 38
Other Significant Developments 39
Apr 27, 2017: Deltex awarded EU Horizon 2020 Phase 1 grant 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Deltex Medical Group Plc, Medical Equipment, Key Facts, 2017 2
Deltex Medical Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Deltex Medical Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Deltex Medical Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Deltex Medical Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Deltex Medical Group Plc, Deals By Market, 2012 to YTD 2018 8
Deltex Medical Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CAS Medical Systems Enters into Distribution Agreement With Deltex Medical 10
Deltex Medical And Uscom Enter Distribution Agreement 11
Deltex Medical Raises USD2.4 Million in Private Placement of Shares 12
Deltex Medical Plans to Raise USD0.5 Million in Rights Offering of Shares 13
Deltex Medical Raises USD0.7 Million in Private Placement of Shares 14
Deltex Medical Raises USD1.8 Million in Rights Offering of Shares 15
Deltex Medical to Raise USD6.7 Million in Private Placement of Shares 16
Deltex Medical Completes Private Placement Of Shares For US$4 Million 17
Deltex Medical Completes Private Placement Of Shares For US$0.2 Million 18
Deltex Medical Group Plc, Key Competitors 19
Deltex Medical Group Plc, Key Employees 20
Deltex Medical Group Plc, Subsidiaries 21

List of Figures
Deltex Medical Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Deltex Medical Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Deltex Medical Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Deltex Medical Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Deltex Medical Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Deltex Medical Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Deltex Medical Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Deltex Medical Group Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Deltex Medical Group Plc (DEMG):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Litha Healthcare Group Ltd-医療機器分野:企業M&A・提携分析
    Summary Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. …
  • Ono Pharmaceutical Co Ltd (4528):企業の財務・戦略的SWOT分析
    Ono Pharmaceutical Co Ltd (4528) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Alcami Corporation:企業の戦略・SWOT・財務情報
    Alcami Corporation - Strategy, SWOT and Corporate Finance Report Summary Alcami Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Biomay AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Biomay AG (Biomay) is a developer of therapeutics for allergy that discovers disease modifying allergy therapeutics. The company develops peptide carrier fusion vaccines for allergy immunotherapy. It provides pipeline product portfolio such as investigation candidates targeted against IgE me …
  • Triangle Energy (Global) Ltd (TEG):企業の財務・戦略的SWOT分析
    Summary Triangle Energy (Global) Ltd (Triangle Energy), formerly Maverick Energy Ltd, is an oil and gas company that explores and produces oil and natural gas reserves. The company operates oil and gas assets such as Reid’s Dome and Pase Field. It holds working interest and operates the Production S …
  • Fresenius Kabi USA LLC:企業の戦略的SWOT分析
    Fresenius Kabi USA LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Blonder Tongue Laboratories, Inc. (BDR):企業の財務・戦略的SWOT分析
    Blonder Tongue Laboratories, Inc. (BDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Uni-President China Holdings Ltd
    Uni-President China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Uni-President China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • AJ Lucas Group Ltd (AJL):企業の財務・戦略的SWOT分析
    AJ Lucas Group Ltd (AJL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Internet Initiative Japan Inc (3774):企業の財務・戦略的SWOT分析
    Internet Initiative Japan Inc (3774) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sfinks Polska S.A.:企業の戦略・SWOT・財務分析
    Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kuwait Petroleum Corporation:企業の戦略的SWOT分析
    Kuwait Petroleum Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Entasis Therapeutics Inc (ETTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Entasis Therapeutics Inc (Entasis) is a drug development company that discovers and develops anti-infective therapies for drug-resistant bacterial infections. The company’s pipeline products include ETX2514, ETX0282, ETX0914 and Zoliflodacin. Its ETX2514 is a potent inhibitor of class A, C, …
  • DPL Inc. (DPL):電力:M&Aディール及び事業提携情報
    Summary DPL Inc. (DPL) a subsidiary of AES Corporation is a diversified energy and utility company. It is engaged in the generation, transmission and distribution of electricity in West Central Ohio. The company provides its services to residential, commercial, and industrial and government customer …
  • First Midwest Bancorp, Inc.:企業の戦略・SWOT・財務情報
    First Midwest Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report Summary First Midwest Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • HOK Group, Inc.:企業の戦略・SWOT・財務情報
    HOK Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary HOK Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Actividades de Construccion y Servicios SA:企業のM&A・事業提携・投資動向
    Actividades de Construccion y Servicios SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Actividades de Construccion y Servicios SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Pizza Inn, Inc:企業の戦略・SWOT・財務情報
    Pizza Inn, Inc - Strategy, SWOT and Corporate Finance Report Summary Pizza Inn, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Mechel:企業の戦略・SWOT・財務情報
    Mechel - Strategy, SWOT and Corporate Finance Report Summary Mechel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Veracyte Inc (VCYT):企業の財務・戦略的SWOT分析
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆